Form 4: UNITED THERAPEUTICS CEO Sells Shares
Insider Transaction (Form 4)
Martine A Rothblatt, Chairperson & CEO and a Director of UNITED THERAPEUTICS Corp, sold 9,500 shares of common stock on October 5, 2026.
Summary
- Option exercise/conversion: acquired 9,500 Common Stock at $117.76 ($1,118,720) on October 5, 2026; holds 333,943 after (Indirect).
- Open-market sale: disposed of 501 Common Stock at $536.26 ($268,665) on October 5, 2026; holds 333,442 after (Indirect).
- Open-market sale: disposed of 905 Common Stock at $537.43 ($486,373) on October 5, 2026; holds 332,537 after (Indirect).
- Open-market sale: disposed of 655 Common Stock at $538.62 ($352,795) on October 5, 2026; holds 331,882 after (Indirect).
- Open-market sale: disposed of 931 Common Stock at $539.50 ($502,279) on October 5, 2026; holds 330,951 after (Indirect).
- Open-market sale: disposed of 1,028 Common Stock at $540.50 ($555,633) on October 5, 2026; holds 329,923 after (Indirect).
- Open-market sale: disposed of 1,239 Common Stock at $541.66 ($671,120) on October 5, 2026; holds 328,684 after (Indirect).
- Open-market sale: disposed of 918 Common Stock at $542.56 ($498,067) on October 5, 2026; holds 327,766 after (Indirect).
- Open-market sale: disposed of 783 Common Stock at $543.54 ($425,593) on October 5, 2026; holds 326,983 after (Indirect).
- Open-market sale: disposed of 1,260 Common Stock at $544.59 ($686,187) on October 5, 2026; holds 325,723 after (Indirect).
- Open-market sale: disposed of 920 Common Stock at $545.69 ($502,037) on October 5, 2026; holds 324,803 after (Indirect).
- Open-market sale: disposed of 360 Common Stock at $546.63 ($196,788) on October 5, 2026; holds 324,443 after (Indirect).
- Option exercise/conversion: disposed of 9,500 Stock Option on October 5, 2026; holds 299,910 after (Indirect).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $5,145,537 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Martine A Rothblatt — Director, Officer (Chairperson & CEO)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-05 | Option exercise/conversion | Common Stock | 9,500 | $118 | $1.1M | 333,943 |
| 2026-10-05 | Open-market sale | Common Stock | 501 | $536 | $268.7K | 333,442 |
| 2026-10-05 | Open-market sale | Common Stock | 905 | $537 | $486.4K | 332,537 |
| 2026-10-05 | Open-market sale | Common Stock | 655 | $539 | $352.8K | 331,882 |
| 2026-10-05 | Open-market sale | Common Stock | 931 | $540 | $502.3K | 330,951 |
| 2026-10-05 | Open-market sale | Common Stock | 1,028 | $540 | $555.6K | 329,923 |
| 2026-10-05 | Open-market sale | Common Stock | 1,239 | $542 | $671.1K | 328,684 |
| 2026-10-05 | Open-market sale | Common Stock | 918 | $543 | $498.1K | 327,766 |
| 2026-10-05 | Open-market sale | Common Stock | 783 | $544 | $425.6K | 326,983 |
| 2026-10-05 | Open-market sale | Common Stock | 1,260 | $545 | $686.2K | 325,723 |
| 2026-10-05 | Open-market sale | Common Stock | 920 | $546 | $502.0K | 324,803 |
| 2026-10-05 | Open-market sale | Common Stock | 360 | $547 | $196.8K | 324,443 |
| 2026-10-05 | Option exercise/conversion | Stock Option | 9,500 | — | — | 299,910 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-05 | Option exercise/conversion (9,500 shares) |
| 2026-10-05 | Open-market sale (501 shares) |
| 2026-10-05 | Open-market sale (905 shares) |
| 2026-10-05 | Open-market sale (655 shares) |
| 2026-10-05 | Open-market sale (931 shares) |
| 2026-10-05 | Open-market sale (1,028 shares) |
| 2026-10-05 | Open-market sale (1,239 shares) |
| 2026-10-05 | Open-market sale (918 shares) |
| 2026-10-05 | Open-market sale (783 shares) |
| 2026-10-05 | Open-market sale (1,260 shares) |
| 2026-10-05 | Open-market sale (920 shares) |
| 2026-10-05 | Open-market sale (360 shares) |
| 2026-10-05 | Option exercise/conversion (9,500 shares) |
Keywords
insider transaction, Form 4, UTHR, UNITED THERAPEUTICS Corp, bearish, Martine A Rothblatt
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.